BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170908
DTEND;VALUE=DATE:20171202
DTSTAMP:20260813T214057
CREATED:20170908T075822Z
LAST-MODIFIED:20170908T081632Z
UID:19042-1504828800-1512172799@ces.b2sg.org
SUMMARY:Faculty Positions in Basic and Translational Cancer Research
DESCRIPTION:The UNC Lineberger Comprehensive Cancer Center\, in collaboration with departments in the School of Medicine and across the entire University of North Carolina Chapel Hill\, seeks exceptional candidates for faculty positions at all levels and at all ranks in basic and translational cancer research. This broad-based recruitment seeks creative scientists in areas\, including but not limited to: animal models and therapy\, signal transduction\, computational and systems biology\, cancer genetics and precision medicine\, tumor virology\, drug development and target validation\, epigenetics and gene expression\, DNA damage and repair\, tumor immunology\, inflammation and cancer\, and stem cells. Applicants should have a strong record of recent accomplishments as a post-doctoral fellow or sustained productivity as an established faculty member. Appointment and rank in an academic department will be determined by the applicantâ??s qualifications. Applications will be reviewed beginning December 1\, 2017 and until the positions are filled.  
URL:https://ces.b2sg.org/event/unc-faculty-cr-sept17/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170924
DTEND;VALUE=DATE:20171025
DTSTAMP:20260813T214057
CREATED:20170924T182550Z
LAST-MODIFIED:20170924T182643Z
UID:19092-1506211200-1508889599@ces.b2sg.org
SUMMARY:Postdoctoral Fellowship - Cancer Biology & Epigenetics
DESCRIPTION:Postdoctoral Researcher positions are available in the Department of Pathology at Duke University School of Medicine. These positions are expected to start on January 2\, 2018 under the direction of Dr. Qianben Wang. The laboratory currently focuses on genome-wide transcriptional regulation in hormone-dependent cancers (Chen Z et al. EMBO Journal\, 2015; Nature Communications\, 2015; Chen K et al. Nature Genetics\, 2015; Sunkel et al. Nucleic Acids Research\, 2016). \nMultiple on-going projects include (1) DNA motif switching in prostate cancer; (2) A novel tumor suppressive role of phosphodiesterases (PDE) in prostate cancer; (3) Fine-scale nucleosome repositioning of enhancers in prostate and breast cancers; (4) Oncogenomic function of the Mediator coactivator in aggressive prostate cancer. \nApplicants must have a Ph.D. (or equivalent) and preference will be given to those who have a solid background in molecular biology\, cancer biology\, biochemistry or genomics. \nTo be considered for the position\, please send a cover letter\, CV\, a summary of research accomplishments and future plans\, and contact information for three referees to qianben.wang@duke.edu with e-mail subject “postdoctoral researcher application”.
URL:https://ces.b2sg.org/event/duke-cancer-bio-epi/
LOCATION:Duke University\, Durham\, NC\, 27708\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/09/duke_logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170924
DTEND;VALUE=DATE:20171025
DTSTAMP:20260813T214057
CREATED:20170924T183922Z
LAST-MODIFIED:20170924T184144Z
UID:19097-1506211200-1508889599@ces.b2sg.org
SUMMARY:Postdoctoral Research Fellow - Geroscience
DESCRIPTION:The Buck Institute is the only independent institute in the U.S. devoted solely to research on aging and age-related diseases such as Alzheimer’s\, Parkinson’s\, cancer\, arthritis\, diabetes\, and stroke. Our mission is to increase the healthspan\, the healthy years of life. Awarded a federal grant to establish interdisciplinary research in a new field called Geroscience\, Buck scientists work in a unique\, collaborative environment that allows scientists to initiate studies quickly and respond to new opportunities in fields such as stem cell research and regenerative medicine. Our scientists represent a variety of complementary fields\, including genetics\, epigenetics\, biochemistry\, molecular biology\, bioenergetics\, age-associated disease; and technological disciplines such as genomics\, proteomics\, protein interaction networks and bio-informatics. \nThe Buck Institute\, which was designed by world famous architect I.M. Pei\, is located in Novato\, California\, 25 miles north of the Golden Gate Bridge. \nReceive training in specific area(s) of research with the aim of progressing towards an independent career. The appointment is for one year up to a usual maximum of three to four years\, each year contingent upon satisfactory progress\, as evaluated by the supervisor/mentor. \nKey Responsibilities: \n– Receive training in specific area(s) to continue the development of personal technical knowledge and research expertise.\n– Under guidance\, design\, plan and execute original research projects or major parts thereof.\n– Develop ability to critically evaluate and analyze data.\n– Keep a careful record of experiments in laboratory notebooks.\n– Publish and present data internally and externally.\n– Assist other institute researchers in areas of personal expertise.\n– Attend and participate in institutional programs\, seminars and lectures.\n– Progress towards an independent career.\n– Encouraged to seek outside training support.\n– Provide other related duties as required \nEducation: \n      PhD in relevant field of study \nPlease complete application and submit CV to be considered for this position.
URL:https://ces.b2sg.org/event/buck-postdoc-geroscience/
LOCATION:Buck Institute\, 8001 Redwood Boulevard\, Novato\, CA\, 94945\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/buck-institute-of-anti-aging-logo-1-e1506278436891.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170924
DTEND;VALUE=DATE:20171025
DTSTAMP:20260813T214057
CREATED:20170924T184747Z
LAST-MODIFIED:20170924T184747Z
UID:19100-1506211200-1508889599@ces.b2sg.org
SUMMARY:Research Associate I
DESCRIPTION:Moffitt Cancer Center is internationally recognized for our focus on personalized cancer care and translational research. The mission of Moffitt is clear\, focused\, and fully stated in nine words\, “To contribute to the prevention and cure of cancer.” With a tradition of excellence that began with the first patient admission in 1986\, dedicated Moffitt physicians\, scientists\, and staff members have remained committed to excellence in an atmosphere characterized by kindness\, caring\, and hope. \nResearch Associate I – Epigenetics and Cancer \nPosition Highlights: \n\nThe laboratory of Dr. Nupam Mahajan at Moffitt Comprehensive Cancer Center is seeking a `Research Associate I’ interested in studying prostate and triple negative breast cancers.\nThe positions involves testing novel small molecule compounds as potential therapeutic agents to overcome drug-resistance and novel immunomodulators.  \n\n\nOur research group has identified novel histone modification marks (Cancer Cell\, 2017; Nature Struc. Mol Biol.2012) and have identified small molecules that could suppress tumor progression (J Med Chem. 58:2746-63\, 2015).  For more information about our work\, visit the website: http://labpages2.moffitt.org/mahajan_n/\n\n  \nThe Ideal Candidate: \n\nWe are looking for a highly motivated individual with BS or MS in molecular biology\, immunology or biochemistry.\nCandidates must be enthusiastic and dedicated to science with excellent organizational skills and effective at working independently\, while also collaborating and assisting the team in its collective research goals.\nAttention to detail and ability to work on multiple projects is must.\nExcellent verbal and written communication skills are required.\n\n  \nResponsibilities: \n\nCandidate is expected to conduct and document experiments independently and evaluate and interpret data with guidance.\nCandidate is also expected to keep meticulous record of data.\nHe/She will also have various lab duties\n\n  \nCredentials and Qualifications: \n\nBS in molecular biology\, immunology\, or biochemistry.\nHands-on research experience\n\nPlease submit your CV and the names of three referees to Dr. Nupam Mahajan at Nupam.mahajan@moffitt.org
URL:https://ces.b2sg.org/event/moffitt-sept17/
LOCATION:Moffitt Cancer Center Magnolia Campus\, 12902 USF Magnolia Drive\, Tampa\, FL\, 33612\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/Moffitt-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170924
DTEND;VALUE=DATE:20171025
DTSTAMP:20260813T214057
CREATED:20170924T190046Z
LAST-MODIFIED:20170924T190046Z
UID:19102-1506211200-1508889599@ces.b2sg.org
SUMMARY:Assistant Professor - Microbiology and Immunology
DESCRIPTION:The mission of the Department of Microbiology & Immunology is to participate in the educational mission of the schools of Medicine\, Dentistry\, and Allied Health Professions\, and to provide significant teaching contributions to graduate education. These teaching related goals are interfaced with a substantial research mission focused primarily on scientific endeavors in the area of epigenetic regulation. \n\nResponsibilities:  \n1. Teaching: The successful candidate will assume the responsibilities as course directors of two 600-level graduate courses\, MICR 607: Techniques in Molecular Biology and Genetics\, and MICR 684: Molecular Biology of Cancer. The successful candidate will develop course objectives and content and actively participate in course and curricular evaluation and development in accordance with program goals. The successful candidate will also be expected to participate in graduate education involving both formal platform presentations and laboratory mentoring.\n2. Research: The successful candidate is expected to maintain a dynamic and well-funded research program in the area of epigenetic gene regulation\, and regulation of mitochondrial function and homeostasis. It is anticipated that the successful candidate will continue to expand his/her research program consistent with the expectations of VCU’s Quest for Distinction.\n3. Service: The candidate for this position will participate in various departmental\, school and university committees and provide service to the profession by participating in journal review\, study section service\, and/or service as an officer of a national society.\n4. Clinical N/A\n5. Other (for instance\, administrative duties\, etc.): No direct administrative duties are associated with this position. \n\nThe candidate must have a PhD degree with at least three years postdoctoral research experience utilizing advanced molecular biology techniques and experience working in the area of mitochondrial epigenetics and transcription control. The candidate must also have a successful publication record and the ability to train others to perform advanced molecular and cellular biology techniques. The candidate must possess the ability to design\, conduct and supervise a research project\, and must be a first author on one or more publications in peer-reviewed scientific journals. The successful candidate will also have demonstrated expertise in undergraduate and graduate level student teaching in the areas covered by the courses he/she will direct.
URL:https://ces.b2sg.org/event/vcu-asst-prof/
LOCATION:Virginia Commonwealth University\, 907 Floyd Ave\, Richmond\, VA\, 23284\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/09/VCU-virginia-commonwealth-e1506279590219.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170930
DTEND;VALUE=DATE:20171031
DTSTAMP:20260813T214057
CREATED:20170930T115320Z
LAST-MODIFIED:20170930T115320Z
UID:19119-1506729600-1509407999@ces.b2sg.org
SUMMARY:Endowed Chair in Pancreatic Cancer Research
DESCRIPTION:The Medical College of Wisconsin (MCW) Department of Surgery and the Pancreatic Cancer Program are recruiting a nationally recognized basic scientist for the newly established “Joel and Arlene Lee Endowed Chair in Pancreatic Cancer Research”. This individual should have an established record of research as evidenced by publications and an active research program.  This position is being recruited at the Associate Professor or Professor level. \n\nThe MCW Pancreatic Cancer Program consists of a cohesive multi-disciplinary team with active investigation in the areas of chemokine signaling\, epigenetics\, and experimental therapeutics. The program has developed a longitudinal\, comprehensive\, and clinically annotated biorepository which includes blood and tissue samples\, as well as a rapid autopsy program and a high-risk screening clinic. Our Pancreatic Cancer Program is characterized by a collaborative and synergistic interaction between our scientists and the clinical team which includes medical\, surgical and radiation oncologists\, as well as unique expertise in pathology\, radiology\, and interventional gastroenterology.  The clinical program is high volume and has a strong portfolio of clinical trials in the neoadjuvant\, locally advanced\, and metastatic disease setting\, including phase I clinical trials and drug development.   \n\n\nSubmit a letter of interest and Curriculum Vitae to Wendy Behrs in the Department of Surgery (wbehrs@mcw.edu) or contact any of the following directly: \n\nDouglas Evans (devans@mcw.edu)\nProfessor and Chair\, Department of Surgery\nRaul Urrutia (rurrutia@mcw.edu)\nProfessor and Director\, Genomic Sciences and Precision Medicine Center\nGwen Lomberk (glomberk@mcw.edu)\nAssociate Professor and Chief\, Division of Research\, Department of Surgery\nSusan Tsai (stsai@mcw.edu)\nAssociate Professor\, Division of Surgical Oncology\, Department of Surgery\nVolkan Adsay (nadsay@mcw.edu)\nProfessor\, Department of Pathology
URL:https://ces.b2sg.org/event/mcw-chair/
LOCATION:Medical College of Wisconsin\, 8701 W Watertown Plank Rd\, Milwaukee\, WI\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/09/medical-college-wisconsin.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170930
DTEND;VALUE=DATE:20171031
DTSTAMP:20260813T214057
CREATED:20170930T120157Z
LAST-MODIFIED:20170930T120626Z
UID:19124-1506729600-1509407999@ces.b2sg.org
SUMMARY:Oncology Discovery Intern
DESCRIPTION:Merck Research Lab’s Oncology Discovery team is seeking a motivated\, creative\, and technically skilled student for a 3- month summer internship. The student should have a strong interest in cancer research and learning about oncology drug discovery. The successful candidate will serve as an\nintegral member of a multidisciplinary drug discovery project team developing novel small molecule inhibitors for epigenetic targets. The candidate will work with a scientific mentor to develop and carry out biochemical\, biophysical\, and/or cell-based assays to characterize potential therapeutic molecules. Students with a background in biochemistry\, molecular or cell biology\, biomedical engineering\, or a related field will be considered. Candidates should have completed 3 years of undergraduate study. \nThe responsibilities of the Oncology Discovery team member include: \n– Design\, execute\, interpret and report in vitro experiments.\n– Assist in developing\, executing\, and troubleshooting biochemical\, biophysical\, and cell-based assay\n– Communicate data clearly and concisely to teams and stakeholders.\n– Monitor\, review\, and critically interpret published work to guide their own research.\n– Collaborate with members from other functional areas\, including medicinal chemistry\, in vivo and in vitro pharmacology and genetics. \nQualifications \nEducation: \n– Required:\nCandidates must be currently pursuing a BS/BA degree in biochemistry\, molecular or cell biology\, biomedical engineering\, or a related field\n– Candidates must be returning to school in Fall of 2018. \nRequired\nExperience: \n– Candidates must be available to work full-time for up to 12 weeks beginning in May or June of 2018\n– Candidates must have completed at least (3) full years of college study by June of 2018\n– Strong desire to develop knowledge of Oncology drug discovery.\n– Experience with basic lab procedures: pipetting\, solution preparation\, plate assays.\n– Experience with basic mammalian cell culture.\n– Demonstrated ability to perform accurate data analysis. \nPreferred Experience: \n– Excellent oral and written communication skills\, including preparation of lab reports and presentations.\n– Strong attention to detail. \nYour role at Merck is integral to helping the world meet new breakthroughs that affect generations to come\, and we’re counting on your skills and inventiveness to help make meaningful contributions to global medical advancement. At Merck\, we’re inventing for life. \nIf you need an accommodation for the application process please email us at staffingaadar@merck.com.
URL:https://ces.b2sg.org/event/merck-onc-intern/
LOCATION:Merck\, 33 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/09/merck.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170930
DTEND;VALUE=DATE:20171031
DTSTAMP:20260813T214057
CREATED:20170930T121439Z
LAST-MODIFIED:20170930T121747Z
UID:19129-1506729600-1509407999@ces.b2sg.org
SUMMARY:Laboratory Technician
DESCRIPTION:The Section of Hematology/Oncology has a proud and long tradition of excellence in research-based patient care and clinical discovery. Ranked among the finest cancer programs in the country\, the Section is comprised of nationally and internationally known faculty with expertise in all major types of malignancies\, blood disorders\, and experimental therapies. Principal contributions are scientific or intellectual\, characterized by originality and creativity. Research related to cancer genetics\, cancer biology and epigenetics.   \nThe Laboratory Technician will perform research related to cancer biology and developmental therapeutics. The laboratory research focuses on understanding the role of genomic and proteomic ongocenic drivers of gastroesophageal and other gastrointestinal cancers. Preclinical cell line and patient xenograft modeling in vitro and vivo respectively. The position requires the ability to perform tasks independently and with minimal supervision. Collaborations with other laboratories and investigators within the Section and Department are routine. \n60% — Performing laboratory techniques such as RNA and DNA extractions\, real time PCR\, genotyping\, immunoblotting\, siRNA\, point mutation\, cell culture\, flow cytometry and other in vitro/vivo cell based assays. \n30% — Collate and analyze data. Maintain accurate\, up-to-date and well-documented records of procedures performed and data generated. Summarize results and assist in interpreting findings including analysis of DNA sequencing. \n10% — Collect and process clinical samples \nExperience: 1-2 years of laboratory experience is required. \nExperience in cell culture\, western blotting\, PCR\, siRNA\, RNA and DNA extractions from cell lines and FFPE tissues preferred. \nPrevious clinical laboratory experience is a plus. \nEducation: Bachelor’s degree in Biology\, Molecular Genetics\, Cell Biology\, Medical Technology\, Biochemistry or related discipline required.  
URL:https://ces.b2sg.org/event/uchicago-labtech-sept17/
LOCATION:University of Chicago\, 5801 S Ellis Ave\, Chicago\, IL\, 60637\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/uni-chicago-e1506773468276.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170930
DTEND;VALUE=DATE:20171031
DTSTAMP:20260813T214057
CREATED:20170930T145334Z
LAST-MODIFIED:20170930T150347Z
UID:19135-1506729600-1509407999@ces.b2sg.org
SUMMARY:Senior Scientist - Gynecology & Obstetrics
DESCRIPTION:Position Summary\nRun day-to-day operations of the Khabele Laboratory within the KU Cancer Center. The person will interact with basic and clinical scientists to support translational research within our cancer center. The candidate must have strong communication skills and work well within a collaborative team. He/she will generate and review results\, troubleshoot assays and help write clinical protocols\, grants and manuscripts.\n\n\nRequired Qualifications\nPhD in a biological science. Strong work ethic\, effective communication skills\, and willingness to work under supervision of the lab director and with other lab members. A strong background in molecular biology.\n\n\nPreferred Qualifications\nAt least 3 years experience in current molecular biology techniques including experience working with chromatin biology and/or epigenetics\, prior willingness to work with mouse models of cancer. Experience with Next Generation Sequencing\, DNA methylation analysis\, ChIP-seq\, cell culture or flow cytometry experience. PCR primer design\, DNA\, RNA and protein\, qRT-PCR\, electrophoresis\, Western blot\, ELISA and other molecular biological techniques.
URL:https://ces.b2sg.org/event/kumc-sensci/
LOCATION:KU Medical Center\,  3901 Rainbow Blvd\, Kansas City\, KS\, 66160\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/09/KUMC_-Kansas-Logo_1207-e1506781629194.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171007
DTEND;VALUE=DATE:20171115
DTSTAMP:20260813T214057
CREATED:20171007T173735Z
LAST-MODIFIED:20171007T173735Z
UID:19187-1507334400-1510703999@ces.b2sg.org
SUMMARY:Postdoctoral Scholar - Free Radical and Radiation Biology
DESCRIPTION:The University of Iowa’s Free Radical and Radiation Biology Program (FRRBP) invites applications from highly-motivated\, recent PHD graduates who have a background in free radical\, radiation\, and/or cancer biology to apply for our upcoming openings on our highly successful and long running NIH National Cancer Institute T32. As the only free radical and radiation biology PhD granting training program in the world\, we are at the forefront of redox biology\, free radical biology\, radiation biology\, and cancer research. The FRRBP is a division of the Department of Radiation Oncology and is part of the Holden Comprehensive Cancer Center and the Carver College of Medicine. It is the only PhD granting program at the University of Iowa that is located in a clinical department. Since the Department of Radiation Oncology currently treats more than 1\,500 cancer patients a year\, this allows our trainees to have unique training opportunities for basic science that rapidly moves into translational research. \n\nDirected by Dr. Douglas R. Spitz\, the Free Radical and Radiation Biology Program has a dynamic mentoring program with highly committed faculty mentors. Our award winning and internationally recognized faculty are a very diverse group of basic scientists\, clinician/physician scientists\, and science educators who are focused on the disciplines of redox cancer biology\, metabolism in cancer therapy responses\, imaging of redox biochemistry\, normal tissue injury in cancer biology\, as well as redox regulation of the cell cycle\, radiation biology\, genetic and epigenetic regulation of cancer biology\, and redox regulation of cancer therapy responses. The goal of the mentors is to train our postdoctoral fellows in free radical and radiation biology relevant research with strong cancer relevance. The emphasis of all training will be the role of free radical and radiation biology in cancer diagnosis\, prevention\, and treatment. The specialized\, hands on training will lead to a successful career in cancer-related fields within biomedical research and education. \n\n Trainee Commitment: Postdoctoral Fellows must dedicate at least 40 hours per week (full-time effort) to the training program. These fellowship appointments are 12 month appointments; however appointments may be renewed for an additional two\, one-year increments\, contingent upon available funding and satisfactory performance. Trainees are expected to take on a leadership/mentorship role in the laboratory for both undergraduate and graduate students. \n\nApplicants should attach a cover letter\, curriculum vitae\, a description of their research program\, and current contact information for 3 potential references. \n\nReview of applications will begin November 15\, 2017 and will remain open until the positions are filled. The earliest date these positions are expected to start will be January 1\, 2018 and no later than June 1\, 2018. \n\nQuestions about the position should be directed to Dr. Douglas R. Spitz\, Professor and Director of the Free Radical and Radiation Biology Program at douglas-spitz@uiowa.edu.
URL:https://ces.b2sg.org/event/uiowa-postdoc-oct17/
LOCATION:University of Iowa\, 285 NEWTON ROAD\, Iowa City\, IA\, 52242\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/07/University_of_Iowa_logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171007
DTEND;VALUE=DATE:20171109
DTSTAMP:20260813T214057
CREATED:20171007T174409Z
LAST-MODIFIED:20171007T174439Z
UID:19189-1507334400-1510185599@ces.b2sg.org
SUMMARY:Postdoctoral Fellow - Experimental Therapeutics-BRI
DESCRIPTION:Postdoctoral position: Characterizing cancer progression and metastasis \nTo develop and characterize solid cancer model systems in order to study epigenetic changes contributing to cancer progression and metastasis. These models will aid in the discovery of promising targets and evaluation of treatment strategies. The overall goal of these pre-clinical studies will be to provide supporting data for the potential clinical translation of novel\, effective therapeutic approaches.     \nPlease include CV with publication record and (if applicable) previous/current grant funding. \nMinimum Education and Skills Required for Consideration: \n\nPh.D. with emphasis in oncology and/or epigenetics\, but will also consider biochemistry\, immunology or microbiology background with experience in cancer or epigenetics research.\nExperience in flow cytometry is preferred\nMouse handling with proficiency in different routes of injection.\nStrong critical thinking skills and ability to troubleshoot.\nStrong command of the English language with the capacity to write and speak scientifically.\nShould be self-motivated\, productive\, and require little to no supervision once trained.
URL:https://ces.b2sg.org/event/coh-postdoc-oct17/
LOCATION:City of Hope\, 1500 East Duarte Road\, Duarte\, 91010\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171007
DTEND;VALUE=DATE:20171109
DTSTAMP:20260813T214057
CREATED:20171007T175540Z
LAST-MODIFIED:20171007T175540Z
UID:19191-1507334400-1510185599@ces.b2sg.org
SUMMARY:Research Technician I
DESCRIPTION:The Motamedi Lab at Massachusetts General Hospital Cancer Center and Harvard Medical School is accepting applications for an entry level Research Technician. Research in the Motamedi lab is focused on deciphering the molecular mechanism of epigenetic inheritance\, with special interest in the role of chromatin and non-coding RNAs in regulating critical biological processes whose disruption lead to a variety of diseases including cancers. Specifically\, we will use the highly tractable model organism Schizosaccharomyces pombe and mammalian cells to identify novel factors and study the molecular contribution of chromatin and non-coding RNAs to gene silencing\, dormancy and metabolism. \n\nWe seek a highly motivated candidate who is planning on a career in research and can make original contributions.  The ideal candidate will be trained in biochemistry or molecular biology and have a demonstrated passion for research. A 2-3 year commitment is desired. \nGenerates and interprets experimental results \nOrganizes and accurately maintains written records of experimental procedures and data generated \nStays well-informed of literature directly relating to the project \nAssists in preparation and editing of manuscripts resulting from data generated in research projects \nParticipates in weekly lab meetings \nPerforms weekly lab tasks including preparing media (plates and liquid media) and lab solutions as well as necessary reagents and lab tools for experiments \nEnsures cleanliness and tidiness of lab and updates the spreadsheet for current location of all lab items\, including chemicals\, small and large equipment and lab tools \nEnsures compliance with all safety regulations. Disposes of chemical waste in accordance with departmental and hospital regulations \nOrders common laboratory reagents\, tracking and recording orders \nPerforms general lab maintenance including maintaining laboratory equipment\, placing service calls when needed \n\nQualifications \n B.S. degree in biology\, chemistry or related field is required\, with substantial laboratory work preferred. Working knowledge of Office programs especially on a MacIntosh computer is required. \nRecent college graduate with significant undergraduate research experience in biochemistry\, genetics\, molecular biology or cell biology. Previous research experience with proteins and RNA will be considered an asset. Must be reliable\, detail oriented\, meticulous in record keeping and capable of working both independently and as part of a team. 
URL:https://ces.b2sg.org/event/mgh-res-tech-oct17/
LOCATION:Massachusetts General Hospital Cancer Cente\, 55 Fruit St\, Boston\, MA\, 02114\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/10/mgh-massachusetts-general-hospital-cancer-center.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171007
DTEND;VALUE=DATE:20171030
DTSTAMP:20260813T214057
CREATED:20171007T181915Z
LAST-MODIFIED:20171007T181915Z
UID:19195-1507334400-1509321599@ces.b2sg.org
SUMMARY:Assistant Professor - Gene Regulation\, Genomics\, and Reproduction
DESCRIPTION:Faculty Position in Gene Regulation\, Genomics\, and Reproduction \nThe Cecil H. and Ida Green Center for Reproductive Biology Sciences\, an endowed basic science research center within the University of Texas Southwestern Medical Center Department of Obstetrics and Gynecology\, is recruiting to fill a newly created Tenure-track Assistant Professor Position. We invite applications from outstanding candidates studying aspects of signaling\, gene regulation\, and genome function\, especially in the areas of chromatin and transcription\, epigenetics\, nuclear endpoints of cellular signaling pathways\, nuclear receptors\, RNA biology\, genome organization\, and genome evolution. We are interested in a wide variety of model systems and experimental approaches\, including biochemistry\, molecular biology\, structural biology\, animal models\, genetics\, genomics\, proteomics\, bioinformatics\, and computational biology. The Green Center’s research programs focus on\, but are not limited to\, reproduction and development in a broad sense\, as well as aspects of endocrinology\, stem cells\, cancer\, metabolism\, inflammation\, immunity\, and neurobiology. \nFor this search\, we are particularly interested in recruiting a candidate who represents one or more of these areas of biology: \n• Signaling\, chromatin\, and gene regulation\, using a wide array of experimental approaches to address fundamental questions in nuclear signaling\, chromatin\, transcription\, epigenetics\, and RNA biology.\n• Molecular biology of female reproductive systems\, from stems cells\, oogenesis\, and fertilization\, to implantation\, placental function\, pregnancy\, and parturition\, using cell-based or physiological models in combination with molecular or genomic approaches.\n• Genomic\, proteomic\, bioinformatic\, computational\, and evolutionary approaches to understanding gene regulation\, using state-of-the-art genomic\, proteomic and computational tools. \nThe Green Center promotes and supports cutting-edge\, integrative\, and collaborative basic research in reproduction\, development\, and related areas of biology\, as well as strong connections between basic and clinical research. This recruitment is part of a major university and department-supported renovation and rejuvenation of The Green Center over the past 6 years. Successful candidates will be housed in a newly renovated state-of-the-art research facility and provided a generous start-up package\, and are expected to establish scientifically rigorous and externally funded research programs and participate in center\, department\, and university teaching and training programs. To learn more about The Green Center\, visit: http://www.utsouthwestern.edu/education/medical-school/departments/green-center/index.html. \nCandidates must have a Ph.D. or M.D. or equivalent in a relevant field of study\, postdoctoral or comparable experience\, and a demonstrated record of research excellence. Applicants should send a letter of application\, curriculum vitae\, and a statement of planned research projects as pdf files to greencenter@utsouthwestern.edu. Please indicate one of the three research areas listed above (Molecular biology of female reproduction; Gene regulation; Genomics) in the subject line of the email. Applicants should also arrange for three letters of reference to be sent directly to the above e-mail address. Review of applications will begin on October 30\, 2017\, and will continue during the 2017-2018 academic year or until the position is filled\, although applicants are encouraged to submit their materials as soon as possible.
URL:https://ces.b2sg.org/event/utsw-asst-prof-oct17/
LOCATION:UT Southwestern Medical Center\, 5323 Harry Hines Blvd.\, Dallas\, TX\, 75390\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/ut-southwestern-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171013
DTEND;VALUE=DATE:20171115
DTSTAMP:20260813T214057
CREATED:20171013T162249Z
LAST-MODIFIED:20171013T162519Z
UID:19210-1507852800-1510703999@ces.b2sg.org
SUMMARY:Human Genetics/WCI Open Rank Faculty Position - Tenure Path
DESCRIPTION:We seek exceptional individuals with dynamic and innovative cancer research programs with a specific focus in cancer genetics\, epigenetics\, and/or genomics. Successful candidates will be expected to maintain an independent federally funded research program and to participate in cancer center activities. This recruiting effort is part of a strategic initiative to create a cadre of first class scientists with closely related research interests in support of Winship’s Cancer Genetics and Epigenetics Research Program.  \n\nPreferred Qualifications: \nSuccessful candidates will hold an PhD\, MD or MD/PhD degree\, postdoctoral training\, and a strong track-record of peer-reviewed research publications and extramural funding.  \nThe Winship Cancer Institute of Emory University (Winship) in partnership with the Department of Human Genetics (DOHG) at Emory University School of Medicine invites applications from outstanding candidates for a tenure-path faculty position at the rank of Assistant\, Associate\, or Full Professor\, commensurate with experience. We seek exceptional individuals with dynamic and innovative cancer research programs with a specific focus in cancer genetics\, epigenetics\, and/or genomics. Successful candidates will be expected to maintain an independent federally funded research program and to participate in cancer center activities. This recruiting effort is part of a strategic initiative to create a cadre of first class scientists with closely related research interests in support of Winship’s Cancer Genetics and Epigenetics Research Program. \n\n\nAdditional Job Details: \nInterested candidates should submit a Cover Letter indicating his/her research interest\, Curriculum vitae\, Statement of research accomplishments and goals (2 pages)\, and names of 3 potential references. \n\n\nThis position involves: \nInvolve potential exposure to hazardous chemicals.\, Involve working with radioactive materials or devices.
URL:https://ces.b2sg.org/event/emory-gen-oct17/
LOCATION:Emory University\, 201 Dowman Dr\, Atlanta\, GA\, 30322\, United States
CATEGORIES:Jobs
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171013
DTEND;VALUE=DATE:20171115
DTSTAMP:20260813T214057
CREATED:20171013T163544Z
LAST-MODIFIED:20171013T165252Z
UID:19213-1507852800-1510703999@ces.b2sg.org
SUMMARY:VP Head of Experimental Medicine Unit
DESCRIPTION:Basic qualifications: \n • M.D.\, PhD\, or MD/PhD degree\n• 10 years pharmaceutical or relevant medical/clinical experience\n• Keen understanding of translational medicine and its role in drug development\n• Experience with translational investigation of cell-based therapy\, cancer immunotherapies and/or cancer epigenetics modifiers is a plus.\n• Relevant experience in translational medicine\, companion diagnosis\, and early phase drug development is an advantage\n• Demonstrated track record of successfully developing and executing Translational Medicine Plan in supporting oncology drug development\n• Proven ability to strategize\, prioritize\, and manage multiple projects simultaneously to ensure quality\, timely\, on-target and within budget accomplishment of tasks.\n• Managerial experience with demonstrated track record of successfully managing high-performance cross-functional matrix teams in a complex organization\n• Ability to lead strategic thinking\n• Ability to discriminate between critical and non-critical activities and to follow established processes while identifying areas for process improvement\n• Attention to detail with excellent planning\, time management and organizational skills\n• Excellent communication and presentation skills\, high- level negotiation skills and the ability to resolve conflict in a constructive manner \nPreferred qualifications: \n As above \nDetails: \n Immuno-Oncology\, Oncology Cell Therapy\, and Cancer Epigenetics are the three strategic research areas of GSK Oncology R&D.\n• GSK Immuno-Oncology is exploring the utility of 4 different modalities in augmenting host anti-cancer immunity —monoclonal antibodies (mAbs)\, bi-specific antibodies\, small molecules\, and cellular therapies. The anti-BCMA antibody-drug conjugate has demonstrated unprecedented efficacy (~60% overall response rate) in refractory/relapsed multiple myeloma. Other lead assets in Immuno-Oncology include the first-in-class anti-ICOS agonist antibody\, anti-OX-40 (CD134) agonist antibody\, and TLR4 agonist.\n• The newly established OCT Discovery Performance Unit (DPU) is focusing on developing cell-based therapeutics for treating various oncologic and hematologic indications. GSK recently excised the early opt-in option for an investigational NY-ESO-1 TCR-modified T cell therapy from AdaptImmune. This novel cell therapy delivered a 50% ORR in synovial sarcoma\, and it being investigated in multiple other solid tumors. The asset was designated as Breakthrough Therapy by the US FDA\, as well as PRIME status by EMA.\n• GSK Cancer Epigenetics develops drug to modulate chromatin and DNA to modulate broad gene expression and treat cancer\, and has one of the most extensive clinical stage pipeline in cancer epigenetics including inhibitors of BET\, LSD1\, and PRMT5. In addition\, there are 2 near clinical stage assets in Cancer Epigenetics portfolio.\nThe Head of Experimental Medicine Unit (EMU)  is a member of the Oncology TA leadership team  (this is a VP level position reporting to the SVP Oncology) and will lead translational medicine teams and is accountable for strategizing and executing the personalized medicine efforts to support all investigational anti-cancer agents from FTIH to POC and registration. This person will be responsible for providing biomarker discovery and companion diagnosis guidance for activities from Candidate Selection through to POC and registration.\nThis  is also accountable for fostering the collaborations with sites in the Oncology Clinical and Translational Consortium (OCTC)\, a network of premium cancer centers around the world\, to leverage external research resources to advance biomarker and translational research of GSK oncology assets.\nPart of the EMU merit is to incubate new scientific concepts and assets that fall in the larger GSK oncology vision but not immediately within the 3 existing DPUs. One of such examples is targeting and modifying tumor microenvironment to further enhance treatment efficacy of cancer immunotherapy \nThe Head of the Experimental Medical Unit (EMU) will lead the translational medicine effort to support asset development in Immuno-Oncology (IO)\, Oncology Cell Therapy (OCT)\, and Cancer Epigenetics (CE).  The EMU is a newly established unit within GSK Oncology Therapeutic Area and focuses on the following efforts.\n • Coordinating execution of clinical biomarker programs for all Oncology clinical assets\n • Enabling of rational asset combinations across DPUs driven by biomarkers\n • Leveraging of the OCTC centers to function as preferred collaborators\n • Developing companion diagnostic\n • Supporting biomarker-driven new clinical designs (e.g. platform and basket trials)\n • Incubating new programs fitting the TA strategy but not within the remit of an existing DPU\n • Centralizing human subject sample handling and vendor buying power\n In close collaboration with TA Clinical and emerging MDTs\, EMU will play a vital role in utilizing personalized medicine approach to expedite the development of innovative therapeutics for treating various oncologic and hematologic indications. \n*LI-GSK\n Please use the cover letter to highlight how you meet the qualifications and competencies for the role. Your CV along with your cover letter will be used to assess your application.
URL:https://ces.b2sg.org/event/gsk-vp-oct17/
LOCATION:gsk\, 1250 S Collegeville Rd\, Collegeville\, PA\, 19426\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/10/GSK-1-e1507913461300.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171013
DTEND;VALUE=DATE:20171115
DTSTAMP:20260813T214057
CREATED:20171013T164611Z
LAST-MODIFIED:20171013T164730Z
UID:19216-1507852800-1510703999@ces.b2sg.org
SUMMARY:Supervisor\, Laboratory & Research
DESCRIPTION:SUMMARY\nThe primary purpose of this position is to provide oversight and technical management in the Department of Epigenetics and Molecular Carcinogenesis laboratory operations.  Maintains the quality and timeliness of all research laboratory operations within budgetary guidelines.  Coordinates workflow issues\, administrative issues\, and operations issues.  \n\nJOB SPECIFIC COMPETENCIES\n\nLaboratory Operations and Supervision  \nMaintain quality and timeliness of all local and remote laboratory operations\, oversees maintenance\, rules and regulations\, cleanliness\, and safety. Works with the Research Department Administrator and Chairman to manage workflow. Identify and resolve overall research laboratory operational issues and interacts with all levels of internal and external sources to resolve problems. Oversight of laboratory compliance and regulatory fitness\, including inspections and safety accreditation with internal and external entities.  Participate\, as a member of the Incident Command Team\, to ensure research is best served in the event of an emergency.  Directly supervise staff and collaboratively work with all facility and laboratory representatives.  Provide development opportunities and ongoing feedback to staff.  May plan\, organize\, coordinate and participate in research scientific projects. Other duties as assigned.\n\nLaboratory Equipment  \nResponsible for major and minor equipment\, including routine maintenance\, service contracts\, and repairs; recommends replacement or purchase of new equipment; reviews and makes recommendation for purchasing based on anticipated work-load. Researches current techniques and arranges demonstrations on equipment. Plans and/or conducts in-service programs. Supervises the use of laboratory equipment and implements safety procedures. Ensures that all employees are properly trained on new equipment. Provides all staff with information on available sources that benefit their positions.\n\nLaboratory Space   \nReviews current laboratory space. Identifies laboratory needs and coordinates with supervisor\, director of facilities\, and research facilities to provide appropriate guidance in order to meet the needs of the laboratory\, department and institution.  Participate and provide input regarding all facility meetings that may impact research operations.\n\nOther duties as assigned.\n\n\n\n\nREQUIREMENTS\n\nEducation: Bachelor’s degree in Medical Technology\, one of the basic sciences or related field.\n\nPreferred Education: Master’s Level Degree.\n\nCertification: None.\n\nPreferred Certification: None.\n\nExperience: Ten years of experience in scientific or experimental research.  With Master’s degree\, six years of experience is required.
URL:https://ces.b2sg.org/event/mdanderson-lab-super/
LOCATION:MD Anderson Cancer Center Smithville\, 1808 Park Rd 1C\, Smithville\, TX\, 78957\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/MDAnderson.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171013
DTEND;VALUE=DATE:20171115
DTSTAMP:20260813T214057
CREATED:20171013T170304Z
LAST-MODIFIED:20171013T170324Z
UID:19222-1507852800-1510703999@ces.b2sg.org
SUMMARY:Medical Director\, Clinical Development
DESCRIPTION:Basic qualifications: \n• M.D. degree with sub-specialty in Oncology and clinical development experience is highly preferred\n• 5 years pharmaceutical or relevant medical/clinical experience\n• Keen understanding of drug development\n• Experience with clinical and translational investigation of cell-based therapy\, cancer immunotherapies and/or cancer epigenetics modifiers is a plus.\n• Relevant experience in early phase drug development and translational medicine is an advantage\n• Demonstrated track record of successfully developing and executing Clinical Development Plans\n• Proven ability to strategize\, prioritize\, and manage multiple projects simultaneously to ensure quality\, timely\, on-target and within budget accomplishment of tasks.\n• Managerial experience with demonstrated track record of successfully managing high-performance cross-functional matrix teams in a complex organization with minimal direct supervision.\n• Ability to embed medical functional skills and strategic thinking into teams\n• Ability to discriminate between critical and non-critical activities and to follow established processes while identifying areas for process improvement \nVision and strategy: a passion to develop novel therapeutics for cancer patients. A deep understanding of areas of unmet clinical need and the ability to integrate this with the drug development activities required to advance compounds to POC and registration trials. Understanding of technical aspects relevant to early drug development in the pharmaceutical industry including knowledge of GCP\, regulatory processes (US and International) is highly desirable. Experience working collaboratively with key external oncology experts is required.\nLeadership: Ability to implement the clinical vision and strategy. To lead intra- and inter-departmental teams\, matrix-manage a cross-functional team with integrity\, flexibility and forthright communication. This requires exceptional interpersonal skills and the ability to meet project objectives by influencing and motivating key partners. Demonstrated alignment with and commitment to GSK Oncology vision and goals.\nJudgment: evidence of good clinical and scientific judgment. Ability to interpret the significance of preclinical and clinical data\, and to anticipate the information that will be needed to satisfy regulatory requirements for early and late phase oncology studies. Ability to progress projects safely and efficiently. Know when to seek advice from colleagues and senior management.\nTeamwork: build and lead clinical development teams and determine what resources and talents are needed for the rapid progression of the projects. Interact effectively across boundaries with other functions and disciplines using influencing\, communication and relationship building skills. Able to secure\, manage and maintain critical partnerships with key business partners.\nCollaborate: form collaborations with key external experts to take world class science and deliver meaningful benefits for patients. \n\nPreferred qualifications: \nAs above \n\nDetails: \nThe Medical Director is accountable for the clinical development of one or more assets in Immuno-Oncology (IO)\, Oncology Cell Therapy (OCT)\, and Cancer Epigenetics (CE). These three Discovery Performance Units (DPUs) focus on developing innovative therapeutics for treating various oncologic and hematologic indications.\nIn IO\, anti-BCMA antibody-drug conjugate has demonstrated unprecedented efficacy (~60% overall response rate) in refractory/relapsed multiple myeloma. Other IO assets include the first-in-class anti-ICOS agonist antibody\, anti-OX-40 agonist antibody\, TLR4 agonist\, and multiple near clinical stage assets.\nIn OCT\, GSK recently excised the early opt-in option for an investigational NY-ESO-1 TCR-modified T cell therapy from AdaptImmune. This novel cell therapy delivered a 50% ORR in synovial sarcoma\, and it being investigated in multiple other solid tumors.\nThe CE clinical pipeline includes multiple clinical stage assets including BET\, LSD1\, and PRMT5 inhibitors.\nThe candidate will be responsible for leading clinical development team(s) consisting of physicians\, clinical scientists and other function representatives\, strategizing development plan\, executing clinical trials\, and managing the development resources and timeline.  This role requires a cross-matrix senior leader to drive an integrated strategy across different indications for each responsible asset\, and to establish combination strategies with various internal and external assets. \nImmuno-Oncology\, Oncology Cell Therapy\, and Cancer Epigenetics are the three strategic research areas of GSK Oncology R&D.\n• GSK Immuno-Oncology is exploring the utility of 4 different modalities in augmenting host anti-cancer immunity —monoclonal antibodies (mAbs)\, bi-specific antibodies\, small molecules\, and cellular therapies. The anti-BCMA antibody-drug conjugate has demonstrated unprecedented efficacy (~60% overall response rate) in refractory/relapsed multiple myeloma. Other lead assets in Immuno-Oncology include the first-in-class anti-ICOS agonist antibody\, anti-OX-40 (CD134) agonist antibody\, and TLR4 agonist.\n• The newly established OCT Discovery Performance Unit (DPU) is focusing on developing cell-based therapeutics for treating various oncologic and hematologic indications. GSK recently excised the early opt-in option for an investigational NY-ESO-1 TCR-modified T cell therapy from AdaptImmune. This novel cell therapy delivered a 50% ORR in synovial sarcoma\, and it being investigated in multiple other solid tumors. The asset was designated as Breakthrough Therapy by the US FDA\, as well as PRIME status by EMA.\n• GSK Cancer Epigenetics develops drug to modulate chromatin and DNA to modulate broad gene expression and treat cancer\, and has one of the most extensive clinical stage pipeline in cancer epigenetics including inhibitors of BET\, LSD1\, and PRMT5. In addition\, there are 2 near clinical stage assets in Cancer Epigenetics portfolio.\nClinical Development at GSK is responsible for the development of the oncology portfolio from First Time In Human (FTIH) clinical trials to Proof-of-Concept studies\, and pivotal registration trials. As these assets are completing early phase development and transitioning into pivotal trial stage\, this is an exciting opportunity to be instrumental in the success of these assets and benefit cancer patients.\nThe Medical Director Oncology will be a senior leader who will lead clinical development teams consisting of physicians\, clinical scientists\, as well as other function area representatives thus being accountable for the clinical development of investigational anti-cancer agents from FTIH to POC and registration. This person may also be responsible for providing medical guidance for activities from Candidate Selection through to POC and registration\, and will require accountability for the provision of design and medical governance for early phase and pivotal clinical studies; development of high quality clinical plans and data analysis strategies that encompass appropriate imaging\, biomarkers\, surrogate endpoints\, and enabling technologies. An essential component of the roles is the building and maintenance of effective business partnerships within GSK Oncology R &D and with external partners and collaborators. Strong self-motivation and perseverance are desired. \n*LI-GSK \nPlease use the cover letter to highlight how you meet the qualifications and competencies for the role. Your CV along with your cover letter will be used to assess your application.
URL:https://ces.b2sg.org/event/gsk-med-dir-oct17/
LOCATION:gsk\, 1250 S Collegeville Rd\, Collegeville\, PA\, 19426\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/10/GSK-1-e1507913461300.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171014
DTEND;VALUE=DATE:20171115
DTSTAMP:20260813T214057
CREATED:20171014T092112Z
LAST-MODIFIED:20171014T092618Z
UID:19224-1507939200-1510703999@ces.b2sg.org
SUMMARY:Two Postdoc Positions - Epigenetics & Translational Cancer Research
DESCRIPTION:Two postdoctoral positions will be available immediately in the laboratory of Dr. Kexin Xu in the Department of Molecular Medicine at the University of Texas Health San Antonio (UTHSA)\, located in San Antonio\, Texas. \nSelected candidates will perform highly interdisciplinary and collaborative scientific research in one or more of the following areas: (1). Explore the roles of epigenetic programs in normal growth and disease formation; (2) Decipher the changes in the epigenetic machineries upon developmental or pathological stimuli; (3) Identify diagnostic/prognostic biomarkers and therapeutic targets for multiple human cancer types; (4) Develop chemical probes and therapeutics for pre-clinical studies and potential clinical applications. Postdocs in these positions are more likely to have close interaction with oncologists and may deal with clinical samples. Please check the lab website at: http://molecularmedicine.uthscsa.edu/FAC_Research.aspx?facID=180. \nThe research program will help the trainees to build up strong expertise and training record in bioinformatics\, multi-omics (genomics\, transcriptomics\, proteomics\, epigenomics and metabolomics) approaches\, animal models and high-throughput screening\, and etc. \nThe UTHSA is the largest university of health science in South Texas and one of four medical schools in the UT System. The affiliated Cancer Therapy & Research Center (CTRC) is one of the NCI-designated national cancer centers in the state of Texas. \nThe applicant should have a Ph.D. degree (or equivalent) in molecular/cellular biology\, cancer biology\, or closely related biological sciences. Prior experience in next-generation sequencing techniques and animal models is a strong plus. \nTo apply:\nPlease send the application package in one single pdf file including a cover letter briefly describing your previous experience and your future research interest/plan\, curriculum vitae with list of publications\, reprints of up to three representative papers and contact information of at least three references to kxuthscsa@gmail.com. You are also welcome to send any inquiries or questions you might have. \nDr. Kexin Xu\nDepartment of Molecular Medicine \nThe University of Texas Health San Antonio\n7703 Floyd Curl Drive\, MC 8257\nSan Antonio\, TX\, 78229-3900\nEmail: kxuthscsa@gmail.com \nThis position will not have faculty title. All postdoctoral appointments are designated as security sensitive positions. The University of Texas Health Science Center at San Antonio is an Equal Employment Opportunity/Affirmative Action Employer including protected veterans and persons with disabilities.
URL:https://ces.b2sg.org/event/uthsa-2postdocs-oct17/
LOCATION:University of Texas Health San Antonio (UTHSA)\, 7703 Floyd Curl Dr\, San Antonio\, TX\, 78229\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/10/UT-health-san-antonion-UTHSA-e1507972723780.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171014
DTEND;VALUE=DATE:20171115
DTSTAMP:20260813T214057
CREATED:20171014T095457Z
LAST-MODIFIED:20171014T095457Z
UID:19229-1507939200-1510703999@ces.b2sg.org
SUMMARY:Two Postdoctoral positions - Cancer and Stem Cells
DESCRIPTION:Two Postdoctoral positions for Cancer Biology (one position) and Pluripotent Stem Cell Biology (one position) in Memorial Sloan-Kettering Cancer Center : New York\, United States \nOne postdoc positions will focus on the embryonic factors involved in the extra-cellular signal transduction pathway to inhibit tumor initiation and progression directly by sequestering protein-protein interactions and indirectly boosting immune activation on multiple cancer models including melanoma\, leukemia\, and neuroblastoma. \nThe other postdoc position will focus on the stem cell factors that regulate epigenetics to control pluripotency and totipotency through controlling innate immunity\, endogenous retrovirus activation\, chromatin structure\, and novel epigenetic markers. \nNo previous research experience on cancer or stem cell research is necessary. \nCandidates should have a PhD or equivalent degree in the early stage of postdoc training. \nIf interested\, please send CV and few sentence of description on the prior research experience and future research interest to StemCellResearchMSKCC(AT)gmail.com \nSloan-Kettering Institute for Cancer Research \nDepartment of Cancer Biology and Genetics \nCenter for Cell Engineering \nCenter for Stem Cell Biology \nhttp://www.mskcc.org/research/cancer-biology-genetics \nhttp://www.mskcc.org/research/lab/kitai-kim \nWeill Medical College of Cornell University \nDepartment of Cell and Developmental Biology \nhttp://gradschool.weill.cornell.edu/faculty/kitai-kim \nJob Type: Full-time \nRequired education: \n\nDoctorate
URL:https://ces.b2sg.org/event/msk-2postdocs-oct17/
LOCATION:Memorial Sloan Kettering\, 1275 York Avenue\, New York\, NY\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/memorial-sloan-kettering.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171014
DTEND;VALUE=DATE:20171115
DTSTAMP:20260813T214057
CREATED:20171014T100204Z
LAST-MODIFIED:20171014T100409Z
UID:19231-1507939200-1510703999@ces.b2sg.org
SUMMARY:Technician position - Cancer Biology & Pluripotent Stem Cell Biology
DESCRIPTION:Technician position for Cancer Biology and Pluripotent Stem Cell Biology in Memorial Sloan-Kettering Cancer Center : New York\, United States \nOne project will focus on the embryonic factors involved in the extra-cellular signal transduction pathway to inhibit tumor initiation and progression directly by sequestering protein-protein interactions and indirectly boosting immune activation on multiple cancer models including melanoma\, leukemia\, and neuroblastoma. \nThe other project will focus on the stem cell factors that regulate epigenetics to control pluripotency and totipotency through controlling innate immunity\, endogenous retrovirus activation\, chromatin structure\, and novel epigenetic markers. \nIf interested\, please send CV and a short description of prior research experience and future career goal (with time frame) to StemCellResearchMSKCC(AT)gmail.com \nSloan-Kettering Institute for Cancer Research \nDepartment of Cancer Biology and Genetics \nCenter for Cell Engineering \nCenter for Stem Cell Biology \nhttp://www.mskcc.org/research/cancer-biology-genetics \nhttp://www.mskcc.org/research/lab/kitai-kim \nWeill Medical College of Cornell University \nDepartment of Cell and Developmental Biology \nhttp://gradschool.weill.cornell.edu/faculty/kitai-kim \nJob Type: Full-time \nRequired education: \n\nBachelor’s
URL:https://ces.b2sg.org/event/msk-tech-oct17/
LOCATION:Memorial Sloan Kettering\, 1275 York Avenue\, New York\, NY\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/memorial-sloan-kettering.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171015
DTEND;VALUE=DATE:20171117
DTSTAMP:20260813T214057
CREATED:20171015T155253Z
LAST-MODIFIED:20171015T155407Z
UID:19235-1508025600-1510876799@ces.b2sg.org
SUMMARY:Assistant\, Associate\, or Full Professor - Regular Title Series
DESCRIPTION:The University of Kentucky Markey Cancer Center invites applications from outstanding candidates at the level of Assistant\, Associate or Full Professor. Faculty with expertise in the following areas are of specific interest: cancer\nmicroenvironment\, cancer genomics\, epigenetic regulation\, oxidative stress\, mitochondria and cancer metabolism\, DNA repair\, and signal transduction. The successful candidate must have a Ph.D.\, M.D. or M.D./Ph.D. degree\, be highly\nproductive and will be expected to bring and maintain a vigorous\, independent\, extramurally funded research program\, as well as participate actively in collaborative investigations and education programs in the University of Kentucky Medical Center. Generous start-up funds\, competitive salary\, and modern laboratory space are available. Endowed chair positions are also\navailable. \nThe NCI-designated Markey Cancer Center is on the campus of the University of Kentucky\, a land-grant institution founded in 1865. Adjacent to downtown Lexington\, the University of Kentucky is nestled in the scenic heart of the\nBluegrass region of Kentucky. Recently ranked as one of the safest\, most creative\, and the brainiest cities in the nation\, Lexington is an ideal location to\nexperience the work-life balance that the University strives to provide to its employees. \nThe review of applications begins immediately and will continue until the positions are filled. \nPlease include the following additional documents:\nSpecific Request 1 – A brief summary of your accomplishments\nSpecific Request 2 – Describe your future research directions\nSpecific Request 3 – 3 letters of reference
URL:https://ces.b2sg.org/event/uk-prof-oct17/
LOCATION:University of Kentucky\, 410 Administration Drive\, Lexington\, KY\, 40506\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/Univ.-of-Kentucky-logo-e1508082584777.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171016
DTEND;VALUE=DATE:20171117
DTSTAMP:20260813T214057
CREATED:20171016T065942Z
LAST-MODIFIED:20171016T065942Z
UID:19240-1508112000-1510876799@ces.b2sg.org
SUMMARY:Faculty Position - Department of Gastroenterology & Hepatology
DESCRIPTION:Position Summary: The Mayo Clinic Department of Gastroenterology and Hepatology in Rochester\, Minnesota is seeking an exceptional Biomedical Scientist.  \nResponsibilities: The successful candidate will run an independent and nationally/internationally recognized research program in molecular and cellular gastroenterology. Research expertise may be in biochemistry\, epigenetics and/or cell biology with focus on mucosal immunology\, hepatobiliary disorders or gastrointestinal cancer. This person will hold academic rank at Mayo Clinic commensurate with experience and qualifications. The successful candidate will be expected to work collaboratively with colleagues and may align with one or more institutional centers (e.g.\, biomedical discovery\, cancer\, individualized medicine\, regenerative medicine). \nLicensure or Certification: Credentials of a successful candidate will include a doctoral degree (PhD\, MD/PhD\, MD) and rigorous postdoctoral training. Junior investigators should have a strong publication record; evidence of successful competition for external funding is preferred. Senior candidates must have a strong publication record and history of NIH or equivalent extramural funding. \nMayo Clinicis an integrated\, multidisciplinary academic medical center with comprehensive programs in medical education and research that span across three group practice and research sites. We support a vibrant and diverse research enterprise\, with programs in basic\, translational\, clinical\, and population sciences. Mayo has world-class faculty\, laboratories\, and state-of-the-art core facilities and biorepositories. The Mayo Clinic Graduate School of Biomedical Sciences trains and supports PhD and MD/PhD students. We offer a highly competitive compensation package with sustained salary support\, capital equipment funding\, technical and computational resources\, and exceptional benefits. U.S. News and World Report ranks Mayo Clinic as the #1 Hospital in the nation overall\, as well as #1 in Gastroenterology.  \nApplications should include a cover letter\, CV\, and a statement of research interests. Specific questions related to the posting should be directed to: \nWilliam A. Faubion\, M.D.\nDepartment of Gastroenterology and Hepatology\nChair\, Search Committee \nC/O Adriana Semko\nsemko.adriana@mayo.edu\nRecruiter: Adriana Semko
URL:https://ces.b2sg.org/event/mayo-faculty-oct17/
LOCATION:Mayo Clinic\, 200 1st St SW\, Rochester\, MN\, 55905\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/mayo-clinic_416x416.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171017
DTEND;VALUE=DATE:20171118
DTSTAMP:20260813T214057
CREATED:20171017T061712Z
LAST-MODIFIED:20171017T061712Z
UID:19243-1508198400-1510963199@ces.b2sg.org
SUMMARY:Research Associate 1-B/H
DESCRIPTION:Research Associate 1-B/H (Job Opening 433091) –  \nResearch associate 1-B/H provides support to principal investigators conducting oncology research within the Comprehensive Cancer Center; actively participates in isolating DNA\, RNA\, and protein from clinical human tissue specimens; participates in planning\, designing and managing research projects investigating genetic\, epigenetic\, and proteomic modifications and experimental therapeutic techniques for the treatment of various cancers; participates in the development and implementation of new and/or revised research methodologies and techniques; designs and executes complex laboratory experiments; performs advanced molecular and cellular techniques including cell culture\, MTS assays\, clonogenic survival assays\, western blot analysis\, immunofluorescence and immunohistochemistry; collects\, analyzes and interprets research data; collaborates with principal investigator to write manuscripts\, articles\, abstracts and research reports for publication in peer-reviewed journals; conducts critical analysis of research literature related to research being investigated; ensures compliance with protocol requirements\, as well as local\, state and federal regulations; and monitors and enforces laboratory safety procedures to ensure compliance with OSHA regulations. \nEducation and experience\nA Masters degree in an appropriate biological/health science or an equivalent combination of education and experience is required. Ability to translate\, adapt and apply academic and/or practical knowledge in the conduct of biological/health science research is required. Experience in a biological/health science research capacity is preferred. Requires successful completion of a background check; selected candidate may be asked to complete a pre-employment physical including a drug screen.
URL:https://ces.b2sg.org/event/osu-res-1bh/
LOCATION:Ohio State University\, Columbus\, OH\, 43210\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/10/Ohio-State-University-Wide.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171017
DTEND;VALUE=DATE:20171118
DTSTAMP:20260813T214057
CREATED:20171017T081024Z
LAST-MODIFIED:20171017T081100Z
UID:19247-1508198400-1510963199@ces.b2sg.org
SUMMARY:Associate Manager – CHM
DESCRIPTION:The Associate Manager will work with an expanding team of research\, clinical and computational investigators working in cancer genomics under the auspices of the Center of Heme Malignancies\, the Department of Pediatrics and the Center for Molecular Oncology at MSKCC. \nWe have a strong research focus on pediatric and blood cancers. In our research we plan to prospectively profile all pediatric cancers by wholegenome\, as well as whole exome sequencing and RNA sequencing and study these alongside cell and patient derived xenograft models. To study the role of genetic and clonal heterogeneity in cancer we study spatially and temporally separated samples and accompany these by single cell derived experimental models. Additionally we routinely profile patients with advanced disease and no available therapeutic treatments\, patients with no known drivers as well as active patients on our clinical trials. \nOur mission is to establish a fully integrated research program that coordinates basic scientific discovery\, early-phase clinical trials\, and drug development. As part of the center’s clinical and research investigations we are generating a wealth of genomic annotation data to inform clinical decision support and develop diagnostic and disease surveillance assays informed by molecular markers. To this effect we are also developing novel methods such as deep molecular barcoding assays for monitoring minimal residual disease and or circulating tumor DNA. \nYou Will: \nThe Associate Manager in Computational Biology will have a strong track record on the development\, implementation and deployment of next generation sequencing pipelines. The candidate will have proven experience in the delivery of high-quality genome profiling analysis data to include wholgenome\, exome and panel sequencing and RNA-sequencing. The candidate will understand well key principles of genome profiling data (sources of error\, quality control\, variant annotation) and will be an expert in genome annotation methods to include variant calling (substitutions\, indels\, structural variation\, copy number alterations)\, assessment of purity and ploidy\, reconstruction of clonal phylogenies and assessment of gene expression. As a senior computational biologist the candidate will also be responsible for the development of novel bioinformatics solutions to address the growing demands of assay development in our laboratories. \nThe candidate will work alongside a team of engineers and computational biologists and will directly lead an expanding team of bioinformatics data scientists. He or She will be directly involved in the experimental design of each project\, data analysis\, co-ordination with clinical and research collaborators and will be responsible for the production of high quality data and attainment of critical project delivery milestones. \nYou Are: \n\nCapable of building strong customer relationships and delivering customer-centric solutions\nA good decision-maker\, with proven success at making timely decisions that keep the organization moving forward\nAble to work effectively in an environment notable for complex\, sometimes contradictory information\nConsistently achieving results\, even under tough circumstances\nAdept at planning and prioritizing work to meet commitments aligned with organizational\nAdept at building partnerships and working collaboratively with others to meet shared objectives and goals\nAn effective communicator\, capable of determining how best to reach different audiences and executing communications based on that understanding\nResilient in recovering from setbacks and skilled at finding detours around obstacles\nAble to operate effectively\, even when things are not clear or the way forward is not obvious\nAdept at learning quickly\, applying insights from past efforts to new situations\n\nYou Need: \n\nMasters or PhD in bioinformatics – or related quantitative discipline.\nAt least 5 years experience in working with wholegenome profiling data to include DNA NGS data\, RNA- Seq and / or epigenetic platforms.\nExperience with development and implementation of next-generation analysis toolkits (PICARD\, GATK\, samtools\, STAR)\nAdvanced programming and analytical skills\nR or R shiny applications\nStrong track record in high-quality data generation\nExperience with parallelized computing\n\nDesired Qualifications: \n\nIT process management\, version control\, and use case testing\nPrior management experience\nWork in CLIA genome analysis environments
URL:https://ces.b2sg.org/event/msk-manager-oct17/
LOCATION:Memorial Sloan Kettering\, 1275 York Avenue\, New York\, NY\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/memorial-sloan-kettering.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171021
DTEND;VALUE=DATE:20180201
DTSTAMP:20260813T214057
CREATED:20171021T145301Z
LAST-MODIFIED:20171021T150555Z
UID:19256-1508544000-1517443199@ces.b2sg.org
SUMMARY:Associate/Full Professor - Pharmacology
DESCRIPTION:Candidates are expected to have a demonstrated record of excellence in research supported \nby NIH grants. \nThe individual will complement departmental programs in one or more of these areas: \n1) stem cell and regenerative biology \n2) epigenetics and transcriptional regulation; \n3) single cell transcriptomics and computational biology; \n4) optogenetic tools to dissect cell signaling;  \n5) cancer immunology; \n6) metabolomics and \n7) acute and chronic inflammation.  \nA highly competitive package is available.  The department has strong research programs \n(http://mcph.uic.edu/home) consistently ranking among the top 10 in NIH funding.  \nCandidates should have current NIH funding and have demonstrated leadership in the field. \nAll candidates are required to have a PhD\, MD or equivalent doctoral degree\, as well as an  \noutstanding publication record of the above mentioned departmental program areas.
URL:https://ces.b2sg.org/event/uic-prof-pharma/
LOCATION:University of Chicago\, 5801 S Ellis Ave\, Chicago\, IL\, 60637\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/University-of-Illinois-College-of-Medicine-at-Chicago-UIC-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171021
DTEND;VALUE=DATE:20180102
DTSTAMP:20260813T214057
CREATED:20171021T172142Z
LAST-MODIFIED:20171021T172142Z
UID:19266-1508544000-1514851199@ces.b2sg.org
SUMMARY:Clinical Leader - Cancer Precision Medicine
DESCRIPTION:The UNC Lineberger Comprehensive Cancer Center and The University of North Carolina School of Medicine seek an exceptional physician scientist to lead our efforts in Cancer Precision Medicine. Over the past decade\, UNC Lineberger emerged as a leader in the NCI TCGA effort. We have developed an infrastructure for sequencing\, bioinformatic analyses\, molecular pathology\, and their application to patient care through a molecular tumor board. We now search for a translational scientist to head the clinical aspects of an expanding program. We are currently developing novel CLIA assays as well as methodologies to perform genomic analysis to identify somatic and germline mutations\, evaluate transcriptome expression using RNA-sequencing\, and characterize immune repertoires using next generation sequencing. We have developed robust applications for data analysis and anticipate that the person leading this group will utilize these other tools they develop to enhance personalized care for cancer patients and prospective clinical trials. The position is tenure track and open to those at all ranks. Applicants should provide evidence of a strong record of clinical\, translational or basic approaches to broad areas of genetics\, genomics\, gene expression\, epigenetics\, proteomics\, tumor immunology\, and/or precision early cancer detection and prevention. Applications will be reviewed by search committee chair Chuck Perou\, PhD and the committee beginning January 1\, 2018 and until the position is filled.  
URL:https://ces.b2sg.org/event/unc-clinical-leader-oct17/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171021
DTEND;VALUE=DATE:20171123
DTSTAMP:20260813T214057
CREATED:20171021T173737Z
LAST-MODIFIED:20171021T173803Z
UID:19268-1508544000-1511395199@ces.b2sg.org
SUMMARY:Postdoctoral Fellow - Inflammation & Epigenetics
DESCRIPTION:We are seeking a motivated postdoctoral fellow to study (1) the biology of Chimeric Antigen Receptor (CAR) T and NK cells and characterize these CAR-T and CAR-NK cells for development of innovative therapies for chronic HIV infection and HIV-related malignancy with the ultimate goal of administering them to patients as part of a future clinical trial (NIH funded); and (2) the cell biology of NK cell\, with a focus on NK cell inhibitory receptor signaling and synapse. \nWe are using molecular\, biochemical\, and imaging strategies\, as well as biophysical approaches for understanding human lymphocyte dysfunction in chronic infectious diseases and cancers. This post-doctoral fellowship or research position will provide the opportunity to apply cutting-edge imaging techniques to study the biology of cytotoxic lymphocytes and CAR cells. This position can also serve as an ideal transition step either to academia or to industry\, which is a great opportunity for someone who acquired experience in basic immunology research to diversify her/is research experience toward clinical research. \nThis position is looking for experience in molecular biology/cloning\, immunology\, and imaging. This post-doctoral fellowship will provide the opportunity to apply cutting-edge techniques to study the biology of cytotoxic lymphocytes and CAR-T and CAR-NK cells in the laboratory of Dongfang Liu\, Ph.D. \nPlease attach with your application\, a cover letter\, and statement of career goals\, CV\, and contact information for 3 references.
URL:https://ces.b2sg.org/event/methodist-postdoc-oct17/
LOCATION:Houston Methodist Research Institute\, 6670 Bertner Ave\, Houston\, TX\, 77030\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/houston-methodist-e1498136597133.jpg
END:VEVENT
END:VCALENDAR